Literature DB >> 15043489

[Cuttoff values of biochemical tests on pleural fluid: their usefulness in differential diagnosis of 1,040 patients with pleural effusion].

J M Porcel-Pérez1, M Vives Soto, A Esquerda Serrano, A Jover Sáenz.   

Abstract

OBJECTIVE: The aim of biochemical pleural fluid testing is to reach an etiological diagnosis of the pleural effusion. We assessed the utility of considering cuttoff points for the wide range of analytes used to investigate pleural fluid. PATIENTS AND METHODS: Among 1,040 patients with pleural effusion, we sought the etiologies of those fluids which showed any of the following characteristics: red blood cell count = 10 x 109/L, leukocytes = 10 x 109/L, percentage of neutrophils or lymphocytes >50%, protein = 50 g/L, glucose = 60 mg/dL, pH = 7.2, lactate dehydrogenase = 1,000 U/L, adenosine deaminase = 40 U/L, amylase = 100 U/L or cholesterol = 60 mg/dL.
RESULTS: Some of the more prominent findings were: a) a sixth of transudates were blood-tinged or contained predominantly neutrophils; b) a groosly bloody fluid suggests malignant disease, trauma, or pulmonary embolization; c) nearly 90% of fluids containing = 10 x 10(9) leukocytes/L were parapneumonics; d) 73% of tuberculous pleural fluids had protein > or = 50 g/L, e) tuberculosis and parapneumonics explained more than 90% of fluids with high adenosine deaminase content; f) one third of amylase-rich pleural effusions were malignant; g) a low pleural glucose or pH levels indicate that patient probably has a parapneumonic, tuberculous or malignant etiology; y h) the diagnostic yield of pleural fluid cytology in malignant effusions was 57%, a percentage which raised to 94% in those with low glucose fluid level.
CONCLUSIONS: Cuttof values of biochemical pleural fluid tests may greatly support particular causes of pleural effusions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043489     DOI: 10.4321/s0212-71992004000300003

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  4 in total

Review 1.  Tuberculous pleural effusion.

Authors:  José M Porcel
Journal:  Lung       Date:  2009-08-13       Impact factor: 2.584

2.  Incidence of pleural effusion in patients with pulmonary embolism.

Authors:  Min Liu; Ai Cui; Zhen-Guo Zhai; Xiao-Juan Guo; Man Li; Lei-Lei Teng; Li-Li Xu; Xiao-Juan Wang; Zhen Wang; Huan-Zhong Shi
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

3.  Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion.

Authors:  Kuan-Yuan Chen; Po-Hao Feng; Chih-Cheng Chang; Tzu-Tao Chen; Hsiao-Chi Chuang; Chun-Nin Lee; Chien-Ling Su; Lian-Yu Lin; Kang-Yun Lee
Journal:  Int J Gen Med       Date:  2016-06-11

4.  Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion.

Authors:  Rachel Mary Mercer; Rebecca Varatharajah; Gillian Shepherd; Qiang Lu; Olalla Castro-Añón; David J McCracken; Alexandra Dudina; Dinesh Addala; Stamatoula Tsikrika; Vineeth George; Radhika Banka; Rachelle Asciak; Maged Hassan; Robert Hallifax; Eihab O Bedawi; Janis Kay Shute; Najib M Rahman
Journal:  BMJ Open Respir Res       Date:  2020-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.